Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis

Advancements in rheumatoid-arthritis-(RA) therapies have shown considerable progresses in the comprehension of disease. However, the development of new potential agents with relative safety and efficacy continues and natural compounds have been considered as alternatives to identify new entities. Si...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International immunopharmacology 2013-06, Vol.16 (2), p.232-242
Hauptverfasser:	Endale, Mehari, Lee, Whi Min, Kwak, Yi-Seong, Kim, Na-Mi, Kim, Bok-Kyu, Kim, Seung-Hyung, Cho, JaeYoul, Kim, Suk, Park, Seung-Chun, Yun, Bong-Sik, Ko, Dukhwan, Rhee, ManHee
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Arthritis, Experimental - blood Arthritis, Experimental - drug therapy Arthritis, Experimental - immunology Arthritis, Experimental - pathology CIA-mice Collagen Type II - immunology Cytokines Cytokines - blood Cytokines - immunology Foot - pathology Immunoglobulin G - blood Inflammation Joints - cytology Leukocyte Count Leukocytes Leukocytes - immunology Lymph Nodes - cytology Male Mice Mice, Inbred DBA Rheumatoid arthritis Sesquiterpenes, Guaiane - pharmacology Sesquiterpenes, Guaiane - therapeutic use Spleen - cytology Torilin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!